These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 25013381

  • 1. MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma.
    Dang Z, Xu WH, Lu P, Wu N, Liu J, Ruan B, Zhou L, Song WJ, Dou KF.
    Int J Biol Sci; 2014; 10(7):733-45. PubMed ID: 25013381
    [Abstract] [Full Text] [Related]

  • 2. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
    Xie F, Li C, Zhang X, Peng W, Wen T.
    Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1.
    Zhou L, Zhang WG, Wang DS, Tao KS, Song WJ, Dou KF.
    Oncol Rep; 2014 Oct; 32(4):1734-40. PubMed ID: 25109303
    [Abstract] [Full Text] [Related]

  • 4. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
    Chang W, Liu M, Xu J, Fu H, Zhou B, Yuan T, Chen P.
    Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic significance of microRNA-141 expression and its tumor suppressor function in human pancreatic ductal adenocarcinoma.
    Zhu ZM, Xu YF, Su QJ, Du JD, Tan XL, Tu YL, Tan JW, Jiao HB.
    Mol Cell Biochem; 2014 Mar; 388(1-2):39-49. PubMed ID: 24242138
    [Abstract] [Full Text] [Related]

  • 7. MiR-940 inhibited pancreatic ductal adenocarcinoma growth by targeting MyD88.
    Song B, Zhang C, Li G, Jin G, Liu C.
    Cell Physiol Biochem; 2015 Mar; 35(3):1167-77. PubMed ID: 25766528
    [Abstract] [Full Text] [Related]

  • 8. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
    Zhao X, Liu Y, Li Z, Zheng S, Wang Z, Li W, Bi Z, Li L, Jiang Y, Luo Y, Lin Q, Fu Z, Rufu C.
    J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MicroRNA‑766 inhibits the malignant biological behaviours of pancreatic ductal adenocarcinoma by directly targeting ETS1.
    Li S, Yan G, Yue M, Kang Z, Wang L.
    Mol Med Rep; 2019 Feb; 19(2):1380-1387. PubMed ID: 30569091
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer.
    Lahdaoui F, Delpu Y, Vincent A, Renaud F, Messager M, Duchêne B, Leteurtre E, Mariette C, Torrisani J, Jonckheere N, Van Seuningen I.
    Oncogene; 2015 Feb 05; 34(6):780-8. PubMed ID: 24608432
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.
    Wang C, Sun Y, Wu H, Yu S, Zhang L, Meng Y, Liu M, Yang H, Liu P, Mao X, Lu Z, Chen J.
    Tumour Biol; 2015 Dec 05; 36(12):9447-56. PubMed ID: 26124009
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
    Jiang Y, Feng E, Sun L, Jin W, You Y, Yao Y, Xu Y.
    Biomed Pharmacother; 2017 Nov 05; 95():685-691. PubMed ID: 28886528
    [Abstract] [Full Text] [Related]

  • 19. ZFP36L2 promotes cancer cell aggressiveness and is regulated by antitumor microRNA-375 in pancreatic ductal adenocarcinoma.
    Yonemori K, Seki N, Kurahara H, Osako Y, Idichi T, Arai T, Koshizuka K, Kita Y, Maemura K, Natsugoe S.
    Cancer Sci; 2017 Jan 05; 108(1):124-135. PubMed ID: 27862697
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.